{"context":{"query":">>hgnc>>gwas","source_dataset":"hgnc","target_dataset":"gwas"},"stats":{"queried":7,"total":279,"mapped":8},"pagination":{"has_next":true,"next_token":"-1[]HGNC:11730,10,HGNC:11730,135,0]["},"schema":"id|disease_trait|mapped_gene|chr_id|p_value","mappings":[{"input":"HOXB13","source":"HGNC:5112|homeobox B13","targets":["GCST001719_1|Prostate cancer|PCAT1, CASC19|8|6.000000e-34","GCST001942_17|Prostate cancer|FLJ40194|17|2.000000e-09","GCST010396_195|Gut microbiota (bacterial taxa, hurdle binary method)|HOXB13 - TTLL6|17|4.000000e-07"]},{"input":"KLK3","source":"HGNC:6364|kallikrein related peptidase 3","targets":["GCST000152_3|Prostate cancer|KLK3 - KLK2|19|2.000000e-18","GCST000919_3|Serum prostate-specific antigen levels|KLK3|19|3.000000e-46","GCST001796_3|Prostate-specific antigen levels|KLK3 - KLK2|19|6.000000e-37","GCST001946_4|PCA3 expression level|KLK2|19|1.000000e-08","GCST002112_14|Celiac disease|KLK2|19|6.000000e-06","GCST002413_1|Prostate cancer (early onset)|KLK3|19|1.000000e-07","GCST002421_4|Prostate cancer|KLK3|19|2.000000e-28","GCST002476_2|Prostate-specific antigen levels|KLK3|19|8.000000e-21","GCST002703_4|Prostate-specific antigen levels|KLK15 - KLK3|19|9.000000e-21","GCST002886_3|Prostate cancer aggressiveness|KLK3|19|6.000000e-09","GCST002944_1|Prostate cancer|KLK15 - KLK3|19|1.000000e-13","GCST004093_14|Prostate-specific antigen levels|KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2|19;19;19;19;19;19;19|8.000000e-17","GCST004093_15|Prostate-specific antigen levels|KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2|19;19;19;19;19;19;19|1.000000e-85","GCST004093_16|Prostate-specific antigen levels|KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2|19;19;19;19;19;19;19|4.000000e-09","GCST004093_17|Prostate-specific antigen levels|KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2|19;19;19;19;19;19;19|1.000000e-07","GCST004093_18|Prostate-specific antigen levels|KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2|19;19;19;19;19;19;19|8.000000e-10","GCST004093_19|Prostate-specific antigen levels|KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2|19;19;19;19;19;19;19|3.000000e-11","GCST004093_20|Prostate-specific antigen levels|KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2|19;19;19;19;19;19;19|2.000000e-45","GCST004093_22|Prostate-specific antigen levels|KLK3|19|0.000000e+00","GCST004093_39|Prostate-specific antigen levels|KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2|19;19;19;19;19;19;19|9.000000e-186","GCST004093_40|Prostate-specific antigen levels|KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2|19;19;19;19;19;19;19|2.000000e-111","GCST004094_10|Prostate-specific antigen levels (conditioned on lead SNPs)|KLK15 - KLK3|19|1.000000e-14","GCST004094_18|Prostate-specific antigen levels (conditioned on lead SNPs)|KLK3|19|2.000000e-25","GCST004094_7|Prostate-specific antigen levels (conditioned on lead SNPs)|KLK15 - KLK3|19|3.000000e-54","GCST004094_9|Prostate-specific antigen levels (conditioned on lead SNPs)|KLK15 - KLK3|19|4.000000e-17","GCST004345_2|Elevated serum prostate-specific antigen levels in healthy men|KLK3 - KLK2|19|8.000000e-20","GCST008860_10|Prostate cancer|KLK3 - KLK2|19|3.000000e-09","GCST008860_9|Prostate cancer|KLK15 - KLK3|19|2.000000e-08","GCST011829_19|Prostate cancer|KLK3|19|3.000000e-08"]},{"input":"KLK3","source":"HGNC:6371|kallikrein B1","targets":["GCST000635_25|Response to statin therapy|F11-AS1|4|3.000000e-06","GCST001217_32|Metabolic traits|KLKB1|4|7.000000e-18","GCST001391_10|Metabolite levels|KLKB1|4|6.000000e-13","GCST001639_20|Metabolite levels|KLKB1|4|4.000000e-12","GCST001762_772|Obesity-related traits|KLKB1|4|9.000000e-08","GCST001853_2|Circulating vasoactive peptide levels|KLKB1|4|4.000000e-52","GCST001853_3|Circulating vasoactive peptide levels|KLKB1|4|1.000000e-122","GCST002388_15|Serum metabolite levels|KLKB1|4|7.000000e-25","GCST002388_2|Serum metabolite levels|KLKB1|4|9.000000e-27","GCST002714_3|Plasma renin activity levels|KLKB1|4|6.000000e-08","GCST002736_2|B-type natriuretic peptide levels|KLKB1|4|2.000000e-11","GCST003590_2|Apolipoprotein A-IV levels|KLKB1|4|6.000000e-14","GCST003793_1|L-arginine levels|KLKB1|4|2.000000e-22","GCST004038_1|Circulating chromogranin peptide levels|KLKB1|4|3.000000e-30","GCST004038_2|Circulating chromogranin peptide levels|KLKB1|4|1.000000e-07","GCST006249_25|Serum metabolite levels|KLKB1|4|6.000000e-14","GCST007638_33|Glycine levels|KLKB1|4|6.000000e-10","GCST008309_4|Cardiac troponin-I levels|KLKB1|4|1.000000e-08","GCST012020_104|Serum metabolite levels|KLKB1|4|6.000000e-23","GCST012021_55|Serum metabolite levels|KLKB1|4|6.000000e-23","GCST012353_24|Serum metabolite concentrations in chronic kidney disease|KLKB1|4|5.000000e-11","GCST012523_4|Venous thromboembolism|KLKB1|4|3.000000e-11"]},{"input":"MSMB","source":"HGNC:7372|microseminoprotein beta","targets":["GCST000152_2|Prostate cancer|MSMB|10|9.000000e-29","GCST000154_2|Prostate cancer|MSMB|10|7.000000e-13","GCST000585_12|Mean corpuscular volume|TIMM23|10|7.000000e-09","GCST000587_9|Mean corpuscular hemoglobin|TIMM23|10|6.000000e-10","GCST000750_8|Prostate cancer|MSMB|10|3.000000e-08","GCST000919_5|Serum prostate-specific antigen levels|MSMB|10|7.000000e-13","GCST001147_13|Prostate cancer|MSMB|10|5.000000e-06","GCST001796_2|Prostate-specific antigen levels|MSMB|10|5.000000e-17","GCST001946_3|PCA3 expression level|MSMB|10|1.000000e-09","GCST002413_7|Prostate cancer (early onset)|MSMB|10|2.000000e-07","GCST002421_2|Prostate cancer|MSMB|10|3.000000e-26","GCST002703_3|Prostate-specific antigen levels|MSMB - RPL23AP61|10|7.000000e-11","GCST002890_7|Prostate cancer|MSMB|10|1.000000e-15","GCST003148_12|Prostate cancer|MSMB|10|4.000000e-08","GCST004093_8|Prostate-specific antigen levels|MSMB|10|1.000000e-50","GCST006585_1077|Blood protein levels|MSMB - RPL23AP61|10|0.000000e+00","GCST008231_1|Prostate cancer|MSMB|10|1.000000e-10","GCST008860_28|Prostate cancer|MSMB|10|5.000000e-10"]},{"input":"HNF1B","source":"HGNC:11630|HNF1 homeobox B","targets":["GCST000050_2|Prostate cancer|HNF1B|17|1.000000e-11","GCST000152_11|Prostate cancer|HNF1B|17|9.000000e-12","GCST000154_7|Prostate cancer|HNF1B|17|1.000000e-09","GCST000712_13|Type 2 diabetes|HNF1B|17|2.000000e-06","GCST000750_9|Prostate cancer|HNF1B|17|1.000000e-12","GCST000919_7|Serum prostate-specific antigen levels|HNF1B|17|6.000000e-11","GCST001040_2|Endometrial cancer|HNF1B|17|7.000000e-10","GCST001147_2|Prostate cancer|HNF1B|17|2.000000e-06","GCST001666_6|Type 2 diabetes|HNF1B|17|2.000000e-11","GCST001941_16|Ovarian cancer|HNF1B|17|8.000000e-10","GCST002128_12|Type 2 diabetes|HNF1B|17|4.000000e-06","GCST002352_51|Type 2 diabetes|HNF1B|17|9.000000e-10","GCST002413_5|Prostate cancer (early onset)|HNF1B|17|1.000000e-06","GCST002592_24|Neuritic plaque|||1.000000e-06","GCST002748_9|Epithelial ovarian cancer|HNF1B|17|2.000000e-08","GCST002855_1|Testicular germ cell tumor|HNF1B|17|1.000000e-09","GCST002890_4|Prostate cancer|HNF1B|17|8.000000e-29","GCST002960_9|Frontotemporal dementia|HNF1B|17|4.000000e-06","GCST003148_14|Prostate cancer|HNF1B|17|6.000000e-08","GCST003400_10|Type 2 diabetes|HNF1B|17|4.000000e-15","GCST003436_4|Endometrial cancer|HNF1B|17|1.000000e-08","GCST003524_6|Endometrial cancer|HNF1B|17|3.000000e-19","GCST003525_5|Endometrial endometrioid carcinoma|HNF1B|17|7.000000e-17","GCST003586_6|Prostate cancer|HNF1B|17|3.000000e-10","GCST003587_13|Cancer|HNF1B|17|1.000000e-09","GCST003588_21|Cancer (pleiotropy)|HNF1B|17|7.000000e-28","GCST004093_9|Prostate-specific antigen levels|HNF1B|17|6.000000e-20","GCST004635_10|Testicular germ cell tumor|HNF1B|17|3.000000e-20","GCST004713_35|Testicular germ cell tumor|HNF1B|17|1.000000e-14","GCST004894_55|Type 2 diabetes|HNF1B|17|3.000000e-15","GCST004904_28|Body mass index|HNF1B|17|6.000000e-09","GCST005047_104|Type 2 diabetes|HNF1B|17|2.000000e-11","GCST005047_2|Type 2 diabetes|HNF1B|17|3.000000e-09","GCST005047_37|Type 2 diabetes|HNF1B|17|7.000000e-06","GCST005434_4|Pancreatic cancer|HNF1B|17|1.000000e-08","GCST005986_25|Blood urea nitrogen levels|HNF1B|17|1.000000e-12","GCST006464_24|Endometrial cancer|HNF1B|17|3.000000e-20","GCST006465_27|Endometrial cancer (endometrioid histology)|HNF1B|17|3.000000e-14","GCST006867_75|Type 2 diabetes|HNF1B|17|9.000000e-22","GCST007209_18|Gallstone disease|HNF1B|17|5.000000e-10","GCST007235_6|Pancreatic ductal adenocarcinoma|HNF1B|17|1.000000e-06","GCST007506_1|Prostate cancer|HNF1B|17|2.000000e-40","GCST007507_10|Benign prostatic hyperplasia and lower urinary tract symptoms|HNF1B|17|3.000000e-10","GCST007513_1|Prostate-specific antigen levels|HNF1B|17|2.000000e-24","GCST007847_115|Type 2 diabetes|HNF1B|17|2.000000e-34","GCST007923_14|Medication use (drugs used in diabetes)|HNF1B|17|1.000000e-11","GCST008062_45|Blood urea nitrogen levels|HNF1B|17|1.000000e-24","GCST008860_17|Prostate cancer|HNF1B|17|5.000000e-27","GCST008860_7|Prostate cancer|HNF1B|17|6.000000e-07","GCST009379_22|Type 2 diabetes|HNF1B|17|1.000000e-09","GCST009379_23|Type 2 diabetes|HNF1B|17|7.000000e-08","GCST009379_24|Type 2 diabetes|HNF1B|17|6.000000e-36","GCST010118_171|Type 2 diabetes|HNF1B|17|6.000000e-61","GCST011350_6|C-reactive protein levels|HNF1B|17|1.000000e-08","GCST011829_13|Prostate cancer|HNF1B - YWHAEP7|17|7.000000e-09","GCST90011898_161|Alanine aminotransferase levels|HNF1B|17|2.000000e-15","GCST90011899_51|Aspartate aminotransferase levels|HNF1B|17|6.000000e-09","GCST90013407_47|Liver enzyme levels (gamma-glutamyl transferase)|HNF1B|17|5.000000e-47","GCST90013663_37|Alanine aminotransferase levels|HNF1B|17|2.000000e-22","GCST90013664_38|Aspartate aminotransferase levels|HNF1B|17|1.000000e-08"]},{"input":"NKX3-1","source":"HGNC:7838|NK3 homeobox 1","targets":["GCST000488_10|Prostate cancer|SINHCAFP3 - NKX3-1|8|3.000000e-30","GCST000750_7|Prostate cancer|SINHCAFP3 - NKX3-1|8|4.000000e-11","GCST003148_9|Prostate cancer|SINHCAFP3 - NKX3-1|8|1.000000e-13","GCST004064_70|Waist-hip ratio|NKX2-6 - STC1|8|5.000000e-09","GCST004093_25|Prostate-specific antigen levels|SINHCAFP3 - NKX3-1|8|4.000000e-34","GCST005957_8|Waist-to-hip ratio adjusted for BMI (age <50)|NKX2-6 - STC1|8|3.000000e-06","GCST005958_18|Waist-to-hip ratio adjusted for BMI (age >50)|NKX2-6 - STC1|8|3.000000e-08","GCST005962_11|Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)|NKX2-6 - STC1|8|5.000000e-11","GCST005992_13|Mean corpuscular hemoglobin concentration|SLC25A37 - RNU4-71P|8|8.000000e-10","GCST005993_56|Mean corpuscular hemoglobin|SLC25A37|8|1.000000e-10","GCST008362_93|Birth weight|ENTPD4-DT - SLC25A37|8|1.000000e-11","GCST008860_26|Prostate cancer|SINHCAFP3 - NKX3-1|8|3.000000e-24","GCST011829_8|Prostate cancer|SINHCAFP3 - NKX3-1|8|8.000000e-16","GCST90002424_3|Prostate cancer|SINHCAFP3 - NKX3-1|8|3.000000e-06"]},{"input":"TERT","source":"HGNC:11730|telomerase reverse transcriptase","targets":["GCST000238_1|Idiopathic pulmonary fibrosis|TERT|5|3.000000e-08","GCST000256_1|Lung cancer|CLPTM1L|5|4.000000e-06","GCST000318_1|Basal cell carcinoma|CLPTM1L|5|4.000000e-12","GCST000439_1|Glioma|TERT|5|2.000000e-17","GCST000439_4|Glioma|TERT|5|4.000000e-14","GCST000506_5|Lung adenocarcinoma|TERT|5|2.000000e-10","GCST000588_8|Red blood cell count|TERT|5|3.000000e-08","GCST000701_3|Testicular germ cell cancer|TERT|5|8.000000e-15","GCST000701_4|Testicular germ cell cancer|TERT - MIR4457|5|1.000000e-23","GCST000761_1|Lung adenocarcinoma|TERT|5|2.000000e-22","GCST000810_2|Lung adenocarcinoma|TERT|5|3.000000e-11","GCST000842_9|Bladder cancer|CLPTM1L|5|5.000000e-07","GCST000919_2|Serum prostate-specific antigen levels|CLPTM1L|5|1.000000e-10","GCST001058_4|Glioma|TERT|5|1.000000e-14","GCST001140_2|Lung cancer|TERT|5|1.000000e-27","GCST001148_2|Prostate cancer|TERT|5|3.000000e-24","GCST001194_1|Glioma|TERT|5|7.000000e-09","GCST001267_5|Melanoma|CLPTM1L|5|3.000000e-08","GCST001298_1|Breast cancer|TERT|5|1.000000e-10","GCST001609_1|Lung adenocarcinoma|TERT|5|3.000000e-40","GCST001633_1|Glioma|TERT|5|4.000000e-09","GCST001740_2|Lung cancer|TERT|5|4.000000e-27","GCST001930_1|Breast cancer|TERT|5|5.000000e-12","GCST001937_31|Breast cancer|TERT|5|7.000000e-09","GCST001968_2|Interstitial lung disease|TERT|5|2.000000e-19","GCST002022_7|Testicular germ cell tumor|TERT - MIR4457|5|5.000000e-24","GCST002240_4|Bladder cancer|CLPTM1L|5|4.000000e-11","GCST002305_2|Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)|TERT|5|1.000000e-07","GCST002331_5|Basal cell carcinoma|CLPTM1L|5|2.000000e-12","GCST002341_1|Telomere length|TERT|5|4.000000e-06","GCST002474_2|Glioma (high-grade)|TERT|5|1.000000e-15","GCST002553_8|Pancreatic cancer|TERT|5|1.000000e-13","GCST002748_10|Epithelial ovarian cancer|TERT|5|9.000000e-09","GCST002842_3|Basal cell carcinoma|CLPTM1L|5|9.000000e-13","GCST002890_13|Prostate cancer|TERT|5|3.000000e-11","GCST003468_11|Chronic lymphocytic leukemia|TERT|5|6.000000e-08","GCST003578_5|Nasopharyngeal carcinoma|CLPTM1L|5|3.000000e-14","GCST003588_5|Cancer (pleiotropy)|TERT|5|2.000000e-10","GCST003605_1|EGFR mutation-positive lung adenocarcinoma|TERT|5|2.000000e-31","GCST003758_3|Pancreatic cancer|TERT - MIR4457|5|2.000000e-08","GCST003775_2|Lung cancer|TERT|5|3.000000e-09","GCST003776_1|Lung adenocarcinoma|TERT|5|1.000000e-08","GCST003780_1|Breast cancer (estrogen-receptor negative)|TERT|5|2.000000e-10","GCST003782_2|Breast cancer|TERT|5|5.000000e-06","GCST003842_2|Breast cancer (estrogen-receptor negative)|TERT|5|3.000000e-14","GCST003842_3|Breast cancer (estrogen-receptor negative)|TERT|5|2.000000e-06","GCST003842_4|Breast cancer (estrogen-receptor negative)|TERT - MIR4457|5|1.000000e-08","GCST003845_6|Breast cancer|TERT|5|8.000000e-28","GCST003845_7|Breast cancer|TERT|5|3.000000e-08","GCST003845_8|Breast cancer|TERT - MIR4457|5|3.000000e-14","GCST004004_14|Mean corpuscular volume|TERT|5|3.000000e-06","GCST004004_30|Mean corpuscular volume|TERT|5|2.000000e-11","GCST004006_31|Mean corpuscular hemoglobin|TERT|5|1.000000e-08","GCST004093_23|Prostate-specific antigen levels|LINC01511|5|9.000000e-13","GCST004142_4|Melanoma|TERT|5|7.000000e-12","GCST004144_12|Thyroid cancer|TERT|5|3.000000e-07","GCST004146_20|Chronic lymphocytic leukemia|TERT|5|6.000000e-10","GCST004347_13|Glioma|TERT|5|3.000000e-66","GCST004348_2|Non-glioblastoma glioma|TERT|5|1.000000e-16","GCST004349_5|Glioblastoma|TERT|5|8.000000e-74","GCST004601_147|Red blood cell count|TERT|5|2.000000e-25","GCST004602_83|Mean corpuscular volume|TERT|5|1.000000e-35","GCST004602_84|Mean corpuscular volume|TERT|5|8.000000e-23","GCST004603_287|Platelet count|TERT|5|3.000000e-20","GCST004607_67|Plateletcrit|TERT|5|2.000000e-41","GCST004607_68|Plateletcrit|TERT|5|4.000000e-35","GCST004610_153|White blood cell count|TERT|5|8.000000e-18","GCST004613_56|Sum neutrophil eosinophil counts|TERT|5|6.000000e-19","GCST004614_104|Granulocyte count|TERT|5|1.000000e-18","GCST004620_150|Sum basophil neutrophil counts|TERT|5|1.000000e-19","GCST004626_119|Myeloid white cell count|TERT|5|6.000000e-19","GCST004629_13|Neutrophil count|TERT|5|8.000000e-20","GCST004630_149|Mean corpuscular hemoglobin|TERT|5|5.000000e-34","GCST004633_51|Neutrophil percentage of white cells|TERT|5|3.000000e-11","GCST004635_30|Testicular germ cell tumor|TERT|5|9.000000e-25","GCST004661_1|Uveal melanoma|CLPTM1L|5|2.000000e-09","GCST004713_19|Testicular germ cell tumor|TERT|5|8.000000e-20","GCST004744_4|Lung adenocarcinoma|TERT|5|4.000000e-35","GCST004747_21|Lung cancer in never smokers|TERT|5|7.000000e-08","GCST004988_568|Breast cancer|TERT|5|8.000000e-17","GCST004988_702|Breast cancer|TERT - MIR4457|5|1.000000e-20","GCST005075_9|Breast Cancer in BRCA1 mutation carriers|TERT|5|4.000000e-16","GCST005076_11|Breast cancer (estrogen-receptor negative)|TERT|5|2.000000e-35","GCST005113_1|Nasopharyngeal carcinoma|CLPTM1L|5|6.000000e-13","GCST005113_8|Nasopharyngeal carcinoma|TERT - MIR4457|5|4.000000e-06","GCST005143_6|Telomere length|TERT|5|6.000000e-06","GCST005287_2|Intrinsic epigenetic age acceleration|TERT|5|1.000000e-12","GCST005434_16|Pancreatic cancer|TERT - MIR4457|5|2.000000e-08","GCST005434_19|Pancreatic cancer|TERT|5|7.000000e-15","GCST005931_10|Glioma|TERT|5|8.000000e-31","GCST005931_11|Glioma|TERT|5|5.000000e-20","GCST005932_6|Glioblastoma|TERT|5|3.000000e-35","GCST005932_7|Glioblastoma|TERT|5|6.000000e-22","GCST005933_7|Non-glioblastoma glioma|TERT|5|1.000000e-06","GCST005933_8|Non-glioblastoma glioma|TERT|5|2.000000e-06","GCST005973_28|White blood cell count|TERT|5|2.000000e-10","GCST005974_14|Neutrophil count|TERT|5|2.000000e-10","GCST005990_38|Non-albumin protein levels|TERT|5|3.000000e-08","GCST005991_82|Platelet count|TERT|5|8.000000e-25","GCST005993_91|Mean corpuscular hemoglobin|TERT|5|4.000000e-33"]},{"input":"ATM","source":"HGNC:795|ATM serine/threonine kinase","targets":["GCST000927_1|Response to metformin in type 2 diabetes (glycemic)|C11orf65|11|3.000000e-09","GCST001267_4|Melanoma|ATM|11|3.000000e-09","GCST002318_167|Rheumatoid arthritis|||1.000000e-08","GCST002318_66|Rheumatoid arthritis|||1.000000e-08","GCST002990_4|Gastric adenocarcinoma (histologically verified)|||2.000000e-07","GCST002990_5|Gastric adenocarcinoma (histologically verified)|||1.000000e-06","GCST002992_5|Gastric cancer|||6.000000e-07","GCST002992_6|Gastric cancer|||3.000000e-06","GCST004142_8|Melanoma|ATM|11|3.000000e-09","GCST004600_150|Eosinophil percentage of white cells|ATM|11|6.000000e-09","GCST004606_207|Eosinophil count|ATM|11|3.000000e-13","GCST004624_192|Sum eosinophil basophil counts|ATM|11|6.000000e-14","GCST004710_7|Renal cell carcinoma|ATM|11|9.000000e-09","GCST005549_14|Alzheimer's disease (late onset)|C11orf65, ATM|11|6.000000e-07","GCST005996_55|Red blood cell count|ATM|11|1.000000e-11","GCST006085_60|Prostate cancer|ATM|11|8.000000e-09","GCST006462_40|Uterine fibroids|ATM|11|3.000000e-12","GCST006462_51|Uterine fibroids|ATM|11|3.000000e-11","GCST006462_52|Uterine fibroids|ATM|11|7.000000e-08","GCST006959_101|Rheumatoid arthritis|CUL5|11|4.000000e-07","GCST007250_11|Nonunion in individuals with fractures|||3.000000e-07","GCST007505_27|Nevus count or cutaneous melanoma|C11orf65, ATM|11|8.000000e-11","GCST008366_17|Leukocyte telomere length|C11orf65|11|7.000000e-12","GCST008366_9|Leukocyte telomere length|C11orf65|11|2.000000e-10","GCST009856_32|Leukocyte telomere length|ATM|11|1.000000e-08","GCST010002_298|Refractive error|C11orf65|11|4.000000e-19","GCST010303_52|Nevus count or cutaneous melanoma|ATM|11|4.000000e-21","GCST010304_41|Cutaneous malignant melanoma|ATM|11|2.000000e-21","GCST90000032_12|Myeloproliferative neoplasms|ATM|11|2.000000e-10","GCST90002381_319|Eosinophil count|ATM|11|3.000000e-29","GCST90002382_519|Eosinophil percentage of white cells|ATM|11|8.000000e-21","GCST90002388_210|Lymphocyte count|C11orf65, ATM|11|6.000000e-10","GCST90002396_513|Mean reticulocyte volume|ATM|11|3.000000e-09"]}]}